687 related articles for article (PubMed ID: 28694914)
1. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
3. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
4. The roles of special proresolving mediators in pain relief.
Zhang LY; Jia MR; Sun T
Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
[TBL] [Abstract][Full Text] [Related]
5. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
6. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.
Calder PC
Biochim Biophys Acta; 2015 Apr; 1851(4):469-84. PubMed ID: 25149823
[TBL] [Abstract][Full Text] [Related]
7. Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation.
Serhan CN; Bäck M; Chiurchiù V; Hersberger M; Mittendorfer B; Calder PC; Waitzberg DL; Stoppe C; Klek S; Martindale RG;
FASEB J; 2024 May; 38(10):e23699. PubMed ID: 38805158
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
Zhang R; He GZ; Wang YK; Zhou KG; Ma EL
Nutrition; 2015 Mar; 31(3):508-14. PubMed ID: 25701342
[TBL] [Abstract][Full Text] [Related]
9. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
Barden AE; Mas E; Mori TA
Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
[TBL] [Abstract][Full Text] [Related]
10. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils?
Martindale RG; Warren MM; McClave SA
Curr Opin Clin Nutr Metab Care; 2016 Mar; 19(2):151-4. PubMed ID: 26828585
[TBL] [Abstract][Full Text] [Related]
11. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
12. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
Kwon Y
Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
[TBL] [Abstract][Full Text] [Related]
13. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
14. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
Duvall MG; Levy BD
Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
[TBL] [Abstract][Full Text] [Related]
15. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
Siriwardhana N; Kalupahana NS; Moustaid-Moussa N
Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.
Devassy JG; Leng S; Gabbs M; Monirujjaman M; Aukema HM
Adv Nutr; 2016 Sep; 7(5):905-16. PubMed ID: 27633106
[TBL] [Abstract][Full Text] [Related]
17. Whey Peptide-Based Formulas With ω-3 Fatty Acids Are Protective in Lipopolysaccharide-Mediated Sepsis.
Tsutsumi R; Horikawa YT; Kume K; Tanaka K; Kasai A; Kadota T; Tsutsumi YM
JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):552-61. PubMed ID: 24492312
[TBL] [Abstract][Full Text] [Related]
18. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
19. Lipids in critical care medicine.
Ott J; Hiesgen C; Mayer K
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):267-73. PubMed ID: 21546231
[TBL] [Abstract][Full Text] [Related]
20. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
